Evolv Technologies Holdings, Inc. filings document the public-company disclosures of an AI-based security screening business with Class A common stock and warrants listed on Nasdaq. Its Form 8-K reports include financial-results releases, Regulation FD disclosures, board and officer changes, stockholder meeting results, credit-agreement disclosures and registration-statement amendments tied to resale securities and warrant exercises.
Proxy materials describe director elections, executive compensation, auditor ratification, board committee matters and shareholder voting procedures. The filings also identify capital-structure elements, including Class A common stock, warrants and subsidiary borrowing arrangements, alongside governance and reporting matters for Evolv’s screening technology operations.
Evolv Technologies Holdings, Inc. Chief Financial Officer George C. Kutsor reported routine equity compensation activity. He exercised restricted stock units to acquire 138,888 shares of Class A common stock, then sold 51,448 shares at a weighted average price of $7.27 per share.
According to the filing, the sale was made solely to cover withholding taxes tied to RSU vesting, rather than as a discretionary stock sale. After these transactions, he directly holds 87,440 shares of Class A common stock and 277,778 RSUs, which vest in three equal annual tranches, each RSU representing a right to receive one share.
Evolv Technologies Holdings, Inc. is asking stockholders to vote at its virtual 2026 annual meeting on electing two Class II directors, approving an advisory say-on-pay resolution, and ratifying PricewaterhouseCoopers LLP as auditor. Holders of Class A common stock as of April 24, 2026 may vote online or by proxy.
The company highlights strong 2025 performance, with revenue of $145.9 million, 40% growth driven by nearly 250 new customers and over 8,000 active systems. Annual Recurring Revenue reached $120.5 million, while net loss narrowed to $33.1 million and Adjusted EBITDA turned positive at $11.1 million. Cash and marketable securities totaled $69.0 million.
The Board emphasizes enhanced governance, including an independent chair, fully independent key committees, refreshed charters, anti-hedging and clawback policies, and director and executive stock ownership guidelines. Executive pay is positioned as performance‑driven, relying heavily on at‑risk incentives, market-based stock units, and rigorous financial targets, and previously received 98% stockholder support in 2025’s say‑on‑pay vote.
Evolv Technologies Holdings, Inc. Schedule 13G/A shows a joint filing by multiple General Catalyst entities regarding Class A Common Stock (CUSIP 30049H102). The filing identifies the reporting persons and their Delaware organization structure and cites a Joint Filing Agreement governing a coordinated filing under Rule 13d-1(k). Item 5 states ownership of 5 percent or less of a class. Specific share counts and percentages refer readers to the cover sheets (Line 9/11) rather than the main text shown.
Evolv Technologies Holdings director Michael Ellenbogen exercised stock options and sold shares in a routine, pre-planned transaction. He exercised 80,745 stock options at an exercise price of $0.24 per share, receiving the same number of Class A Common shares.
On the same day, he sold 80,745 Class A Common shares at a weighted average price of $6.32 per share under a Rule 10b5-1 trading plan. After these transactions, he directly owned 2,083,961 Class A Common shares and indirectly held 151,135 shares through the Family Horizon Trust.
Evolv Technologies Holdings, Inc. amends its registration statement to convert the filing back to a Form S-3 and to continue the resale registration that covers 158,574,790 shares of Class A common stock and 5,700,000 private placement warrants, plus up to 14,325,000 shares issuable upon exercise of outstanding public and private warrants. The resale is by selling securityholders from time to time; the company will not receive proceeds from those resale transactions. The company would receive proceeds only if warrants are exercised for cash — the filing states aggregate cash proceeds of approximately $131.8 million if all outstanding warrants are exercised. The prospectus also discloses shares outstanding of 179,350,739 as of March 3, 2026 and market quotes of $6.05 per share and $0.116 per warrant as of March 31, 2026.
Evolv Technologies Holdings Inc: The Vanguard Group filed Amendment No. 3 to a Schedule 13G/A reporting 0 shares beneficially owned of Common Stock, representing 0% of the class as of 03/13/2026.
The filing includes a disclosure that Vanguard completed an internal realignment on 01/12/2026, after which certain subsidiaries report ownership separately in reliance on SEC Release No. 34-39538. The statement is signed by Ashley Grim, Head of Global Fund Administration, dated 03/26/2026.
Evolv Technologies Holdings, Inc. describes itself as an AI-powered security technology company providing Security-as-a-Service weapons screening solutions for high-traffic venues such as schools, hospitals, sports and entertainment sites, industrial workplaces and houses of worship. Its Evolv Express and Evolv eXpedite platforms combine proprietary sensors, AI software, cloud connectivity and analytics under multi-year subscription or purchase-plus-subscription models.
The company reports continued losses, with net losses of $33.1 million in 2025 and $54.0 million in 2024, and an accumulated deficit of $387.8 million. As of June 30, 2025, the aggregate market value of common stock held by non‑affiliates was about $999.0 million, and as of March 3, 2026, there were 179,350,739 Class A shares outstanding.
Evolv highlights recurring revenue metrics such as ARR and remaining performance obligations, a large addressable market of roughly 400,000 sites and 700,000 screening thresholds, and a strategy centered on metropolitan “lighthouse” customers, reseller expansion, new products and international growth. The filing also discloses material weaknesses in internal control over financial reporting that led to prior restatements, notes that remediation is ongoing, and warns of risks from supply chain dependence, competition, government regulation, and the possibility that its AI-based systems may fail or be perceived to fail to detect threats.
Evolv Technologies Holdings, Inc. reported strong fourth quarter and full-year 2025 results and raised its outlook for 2026. Q4 2025 revenue reached $38.5 million, up 32% year over year, with ending ARR of $120.5 million, up 21%. The company generated Q4 net income of $10.9 million and Adjusted EBITDA of $1.8 million.
For 2025, revenue grew to $145.9 million, a 40% increase from 2024, while net loss narrowed to $33.1 million and Adjusted EBITDA improved to $11.1 million. Operating activities provided $18.7 million of cash, and cash, cash equivalents and marketable securities totaled $69.0 million at year-end.
For 2026, the company expects total revenue of $172–$178 million and ending ARR of $145–$150 million, with positive full-year Adjusted EBITDA and margins in the high single digits, driven by a higher mix of recurring subscription revenue.